SEC Form 4/A · accession 0001213900-26-086696
Tiziana Life Sciences Ltd · TLSA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Gabriele M Cerrone
Director · 10% Owner
Period of report
Jun 12, 2026
Accepted (ET)
Aug 7, 2026 · 4:15 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001723069
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | Jun 12, 2026 | P | 15,000 | $1.11 | A | 44,772,230 | I | Via Panetta Partners Limited |
Table II — derivative securities
No Table II lines on this filing.
Remarks
This Form 4/A amends the Form 4 filed on June 17, 2026 solely to correct the transaction code associated with this open market purchase. No other reported transactions are affected by this amendment.